SEC Filing Summary: SuperX AI Technology Ltd (Form 6-K)
Business Context and Reporting Period
This Form 6-K filing covers the month of November 2025 for SuperX AI Technology Limited, a foreign private issuer headquartered in Singapore. The report discloses a specific corporate action regarding executive compensation rather than periodic financial results.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to a disclosure of an employment agreement amendment and contains no financial statements or operational metrics.
Material Changes
On November 28, 2025, the Company entered into an addendum to the employment agreement with Dr. Chenhong Huang, originally dated November 15, 2025. The material change involves updating the reference date used to calculate the number of shares issuable for Dr. Huang's equity award. The new reference date is the closing price of the Company's ordinary shares on the trading day immediately preceding Dr. Huang's onboarding date (November 28, 2025). All other terms of the original agreement remain unchanged.
Guidance, Outlook, and Risks
The filing does not contain management commentary, financial guidance, outlook, or a discussion of risks and contingencies. The document focuses solely on the execution of the addendum to the employment contract.
Investor Verification Checklist
- Verify the closing share price on November 27, 2025, to determine the exact number of shares issuable to Dr. Chenhong Huang.
- Review the full text of the Addendum (Exhibit 10.1) to confirm no other terms were altered.
- Check subsequent filings for the actual issuance of shares and any related dilution impact.
- Confirm Dr. Huang's official onboarding date to ensure the correct pricing reference was applied.